Clinical Trial Update: PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial exploring intraperitoneal perfusion of a PD-1 inhibitor combined with PRaG therapy for malignant ascites in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Ascites

Drugs mentioned

• PD-1 inhibitor
• PRaG Therapy

Snippet

Sponsor: Second Affiliated Hospital of Soochow University | Conditions: Malignant Ascites | Phase 1, Phase 2 | Status: UNKNOWN